From: Real-world costs of autosomal dominant polycystic kidney disease in the Nordics
Type of data | Country | Source |
---|---|---|
Direct costsa | Denmark | Danish Medicines Agency [13] Statens Serum Institut [14] The Capital Region of Denmark [15] Rigshospitalet [16] |
Finland | Pharmaceuticals Pricing Board [17] The Social Insurance Institution of Finland [18] The Hospital District of Helsinki and Uusimaa [19, 20] National institute for health and welfare [21] Kuopio University Hospital [22] | |
Norway | Norwegian Medicines Agency [23] Norwegian Directorate of Health [24, 25] Ministry of Health and Care Services [26] | |
Sweden | Dental and Pharmaceutical Benefits Agency [27] Swedish Association of the Pharmaceutical Industry [12] Region Skåne [28] Stockholm County Council [29] | |
Indirect costs | Denmark | Eurostat [32] KPMG [33] |
Finland | ||
Norway | KPMG [33] | |
Sweden | Swedish Tax Agency [41] |